NUTEX HEALTH INC (NUTX) Fundamental Analysis & Valuation

NASDAQ:NUTX • US67079U3068

Current stock price

88.99 USD
-5.67 (-5.99%)
At close:
88.99 USD
0 (0%)
After Hours:

This NUTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NUTX Profitability Analysis

1.1 Basic Checks

  • NUTX had positive earnings in the past year.
  • NUTX had a positive operating cash flow in the past year.
  • In the past 5 years NUTX reported 4 times negative net income.
  • In multiple years NUTX reported negative operating cash flow during the last 5 years.
NUTX Yearly Net Income VS EBIT VS OCF VS FCFNUTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

  • NUTX has a Return On Assets of 11.83%. This is amongst the best in the industry. NUTX outperforms 96.04% of its industry peers.
  • NUTX's Return On Equity of 35.96% is amongst the best of the industry. NUTX outperforms 95.05% of its industry peers.
  • NUTX has a better Return On Invested Capital (38.79%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 11.83%
ROE 35.96%
ROIC 38.79%
ROA(3y)-33.97%
ROA(5y)-688.28%
ROE(3y)-160.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUTX Yearly ROA, ROE, ROICNUTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • Looking at the Profit Margin, with a value of 11.63%, NUTX belongs to the top of the industry, outperforming 98.02% of the companies in the same industry.
  • The Operating Margin of NUTX (35.72%) is better than 99.01% of its industry peers.
  • NUTX's Gross Margin of 55.01% is fine compared to the rest of the industry. NUTX outperforms 76.24% of its industry peers.
  • NUTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.72%
PM (TTM) 11.63%
GM 55.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.83%
GM growth 5Y0.83%
NUTX Yearly Profit, Operating, Gross MarginsNUTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. NUTX Health Analysis

2.1 Basic Checks

  • NUTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for NUTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUTX Yearly Shares OutstandingNUTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
NUTX Yearly Total Debt VS Total AssetsNUTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.91 indicates that NUTX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • NUTX's Altman-Z score of 2.91 is fine compared to the rest of the industry. NUTX outperforms 63.37% of its industry peers.
  • NUTX has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
  • NUTX has a better Debt to FCF ratio (1.87) than 79.21% of its industry peers.
  • NUTX has a Debt/Equity ratio of 0.95. This is a neutral value indicating NUTX is somewhat dependend on debt financing.
  • NUTX has a Debt to Equity ratio (0.95) which is in line with its industry peers.
  • Even though the debt/equity ratio score it not favorable for NUTX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Altman-Z 2.91
ROIC/WACC5.38
WACC7.21%
NUTX Yearly LT Debt VS Equity VS FCFNUTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 3.20 indicates that NUTX has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.20, NUTX belongs to the best of the industry, outperforming 85.15% of the companies in the same industry.
  • NUTX has a Quick Ratio of 3.18. This indicates that NUTX is financially healthy and has no problem in meeting its short term obligations.
  • NUTX has a Quick ratio of 3.18. This is amongst the best in the industry. NUTX outperforms 85.15% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 3.18
NUTX Yearly Current Assets VS Current LiabilitesNUTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NUTX Growth Analysis

3.1 Past

  • NUTX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.86%.
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.12%

3.2 Future

  • NUTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.65% yearly.
  • The Revenue is expected to grow by 3.24% on average over the next years.
EPS Next Y138.53%
EPS Next 2Y71.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.69%
Revenue Next 2Y3.24%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NUTX Yearly Revenue VS EstimatesNUTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
NUTX Yearly EPS VS EstimatesNUTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

9

4. NUTX Valuation Analysis

4.1 Price/Earnings Ratio

  • NUTX is valuated reasonably with a Price/Earnings ratio of 9.91.
  • 90.10% of the companies in the same industry are more expensive than NUTX, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.23. NUTX is valued rather cheaply when compared to this.
  • NUTX is valuated cheaply with a Price/Forward Earnings ratio of 4.15.
  • Based on the Price/Forward Earnings ratio, NUTX is valued cheaper than 98.02% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of NUTX to the average of the S&P500 Index (23.28), we can say NUTX is valued rather cheaply.
Industry RankSector Rank
PE 9.91
Fwd PE 4.15
NUTX Price Earnings VS Forward Price EarningsNUTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUTX indicates a rather cheap valuation: NUTX is cheaper than 98.02% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, NUTX is valued cheaper than 97.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.61
EV/EBITDA 2.22
NUTX Per share dataNUTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • NUTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NUTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as NUTX's earnings are expected to grow with 71.65% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y71.65%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUTX Dividend Analysis

5.1 Amount

  • NUTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NUTX Fundamentals: All Metrics, Ratios and Statistics

NUTEX HEALTH INC

NASDAQ:NUTX (3/20/2026, 7:15:04 PM)

After market: 88.99 0 (0%)

88.99

-5.67 (-5.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-05
Earnings (Next)05-11
Inst Owners38.08%
Inst Owner Change8.33%
Ins Owners2.39%
Ins Owner Change0%
Market Cap629.16M
Revenue(TTM)N/A
Net Income(TTM)114.07M
Analysts82.22
Price Target255 (186.55%)
Short Float %18.26%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.28
Dividend Growth(5Y)N/A
DP39.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)298.6%
Min EPS beat(2)-0.77%
Max EPS beat(2)597.97%
EPS beat(4)3
Avg EPS beat(4)2386.61%
Min EPS beat(4)-0.77%
Max EPS beat(4)8939.67%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.29%
Min Revenue beat(2)7.78%
Max Revenue beat(2)22.8%
Revenue beat(4)4
Avg Revenue beat(4)79.58%
Min Revenue beat(4)7.78%
Max Revenue beat(4)211.33%
Revenue beat(8)7
Avg Revenue beat(8)41.36%
Revenue beat(12)8
Avg Revenue beat(12)27.1%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.16%
Valuation
Industry RankSector Rank
PE 9.91
Fwd PE 4.15
P/S 0.64
P/FCF 3.61
P/OCF 3.54
P/B 1.98
P/tB 2.23
EV/EBITDA 2.22
EPS(TTM)8.98
EY10.09%
EPS(NY)21.42
Fwd EY24.07%
FCF(TTM)24.65
FCFY27.7%
OCF(TTM)25.15
OCFY28.26%
SpS138.78
BVpS44.86
TBVpS39.84
PEG (NY)0.07
PEG (5Y)N/A
Graham Number95.21
Profitability
Industry RankSector Rank
ROA 11.83%
ROE 35.96%
ROCE 44.98%
ROIC 38.79%
ROICexc 49.2%
ROICexgc 52.2%
OM 35.72%
PM (TTM) 11.63%
GM 55.01%
FCFM 17.76%
ROA(3y)-33.97%
ROA(5y)-688.28%
ROE(3y)-160.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.83%
GM growth 5Y0.83%
F-Score8
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Debt/EBITDA 0.81
Cap/Depr 17%
Cap/Sales 0.36%
Interest Coverage 117.8
Cash Conversion 47.91%
Profit Quality 152.79%
Current Ratio 3.2
Quick Ratio 3.18
Altman-Z 2.91
F-Score8
WACC7.21%
ROIC/WACC5.38
Cap/Depr(3y)59.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.52%
EPS Next Y138.53%
EPS Next 2Y71.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-41.12%
Revenue Next Year3.69%
Revenue Next 2Y3.24%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1170.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1313.93%
EBIT Next 3Y163.37%
EBIT Next 5YN/A
FCF growth 1Y3319.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2258.27%
OCF growth 3YN/A
OCF growth 5YN/A

NUTEX HEALTH INC / NUTX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NUTEX HEALTH INC (NUTX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to NUTX.


Can you provide the valuation status for NUTEX HEALTH INC?

ChartMill assigns a valuation rating of 9 / 10 to NUTEX HEALTH INC (NUTX). This can be considered as Undervalued.


What is the profitability of NUTX stock?

NUTEX HEALTH INC (NUTX) has a profitability rating of 6 / 10.


What is the expected EPS growth for NUTEX HEALTH INC (NUTX) stock?

The Earnings per Share (EPS) of NUTEX HEALTH INC (NUTX) is expected to grow by 138.53% in the next year.


How sustainable is the dividend of NUTEX HEALTH INC (NUTX) stock?

The dividend rating of NUTEX HEALTH INC (NUTX) is 0 / 10 and the dividend payout ratio is 39.41%.